This working group of the International Society of Hepatic Encephalopathy and Nitrogen
Metabolism (ISHEN) was commissioned to summarize and update current efforts in the …

Commonly, the angiogenic growth factors signify healing. However, gastrointestinal
ulceration is still poorly understood particularly with respect to a general pharmacological …

We reviewed stable gastric pentadecapeptide BPC 157-NO-system-relation, its close
participation in Moncada's (maintained vascular integrity, platelets control) homeostatic …

Stable gastric pentadecapeptide BPC 157 is an anti-ulcer peptidergic agent, proven in
clinical trials to be both safe in inflammatory bowel disease (PL-10, PLD-116, PL 14736) and …

Background and purpose We focused on the, yet undescribed, therapy effect of the stable
gastric pentadecapeptide BPC 157 in hippocampal ischemia/reperfusion injuries, after …

Paracetamol, caffeine and ibuprofen are found in over‐the‐counter pharmaceutical
formulations. In this work, we propose two new methods for simultaneous determination of …

Stable gastric pentadecapeptide BPC 157 is an anti-ulcer peptidergic agent, safe in
inflammatory bowel disease clinical trials (GEPPPGKPADDAGLV, MW 1419, PL 14736) and …

Aims Radiation-induced liver disease (RILD) is the major complication for cancer patients
after radiation therapy. We investigated the protective effects of BPC 157 peptide in reducing …

AIM To provide new insights in treatment of colitis and ischemia and reperfusion in rats
using stable gastric pentadecapeptide BPC 157. METHODS Medication [BPC 157, L-NAME …

Years ago, we revealed a novel cytoprotective mediator, stable gastric pentadecapeptide
BPC 157, particular anti-ulcer peptide that heals different organs lesions when given as a …